Abilify Asimtufii
Payments companies reported to CMS as associated with Abilify Asimtufii. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Abilify Asimtufii, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Abilify Asimtufii
These are the largest totals companies reported as associated with Abilify Asimtufii. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Henry Nasrallah | Cincinnati, OH | Psychiatry | $233,074.61 |
| Rifaat El-Mallakh | Louisville, KY | Psychiatry | $214,241.53 |
| Rebecca Roma | Pittsburgh, PA | Psychiatry | $193,044.63 |
| Tracey Skale | Cincinnati, OH | Psychiatry | $188,864.11 |
| Michael Measom | Slc, UT | Psychiatry | $168,068.72 |
| Suresh Sureddi | Plano, TX | Psychiatry | $166,025.89 |
| Kent Mcdaniel | Glen Allen, VA | Psychiatry | $154,986.20 |
| Ilan Melnick | Coral Gables, FL | Psychiatry | $147,509.45 |
| Charles Tuan-Tu Nguyen | Irvine, CA | Psychiatry | $143,458.95 |
| Matthew Brams | Houston, TX | Psychiatry | $128,366.60 |
Prescribed Abilify Asimtufii?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.